Stock Market Reviews

GBIO (Generation Bio Co.) News

Get the latest news, insights, and market updates on GBIO (Generation Bio Co.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• We're Keeping An Eye On Generation Bio's (NASDAQ:GBIO) Cash Burn Rate
  There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
  Jun 25, 2025 - $GBIO
• Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
  CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 4th at 8:10 a.m. ET. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generati
  May 28, 2025 - $GBIO
• Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
  Generation Bio (GBIO) delivered earnings and revenue surprises of 12% and 464.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
  May 7, 2025 - $GBIO
• Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
  - Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid-2025 - Cash balance of $157.6 million expected to fund operations into 2H 2027 CAMBRIDGE, MASS., May 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with
  May 7, 2025 - $GBIO
• Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
  CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th at 12:45 p.m. ET. A live webcast of the presentation will be available on the investor section of the c
  Apr 2, 2025 - $GBIO
• Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
  Generation Bio (GBIO) delivered earnings and revenue surprises of -14.29% and 6.95%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
  Mar 13, 2025 - $GBIO
• Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
  - Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 - Cash balance of $185.2 million expected to fund operations into 2H 2027 CAMBRIDGE, MASS., March 13, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, reported business highlights and fourth
  Mar 13, 2025 - $GBIO
• Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
  CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. ET in Boston. A live webcast of the presentation will be available on the investor section of the company’s website at
  Feb 24, 2025 - $GBIO
• 3 US Penny Stocks With Market Cap Under $70M
  As the S&P 500 edges toward new highs amidst mixed trading sessions, investors are paying close attention to smaller market segments for potential opportunities. Penny stocks, though an older term, continue to represent a compelling area of interest due to their association with smaller or emerging companies that might offer significant growth potential. By focusing on those with strong financials and solid fundamentals, investors can find unique opportunities in this often-overlooked segment...
  Jan 23, 2025 - $GBIO
• Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?
  Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
  Jan 16, 2025 - $GBIO